Next-generation sequencing role in pharmacogenetics and pharmacogenomics
Next-generation sequencing (NGS) represents an efficient and reliable method to evaluate the contribution of both common and rare...
top of page
Companion Diagnostics Development
Facilitating personalised treatment
Companion Diagnostics Innovation
Leveraging our diagnostic development expertise and clinical experience to create companion diagnostics that are critical for identifying the right patients for the right treatments, enabling a more precise, targeted approach to treatment, improving patient outcomes, and advancing the field of medicine, from clinical trials through to commercialisation.
Development & Optimisation
Creating assays that can detect biomarkers with high sensitivity and specificity involve leveraging our expertise in NGS to develop reliable, reproducible diagnostic solutions.
Biomarker Discovery & Validation
Identifying and validating biomarkers that predict the efficacy and safety of pharmaceuticals, ensuring that treatments can be personalised to individual genetic profiles.
Regulatory Excellence
Navigating the complex regulatory landscape of companion diagnostics, which involves close coordination with drug development timelines and regulatory submissions. Our team is driven to ensure that our solutions meet all relevant regulatory requirements.
bottom of page